EMERGENT BIOSOLUTI financial statements, including revenue, expenses, profit, and loss

The total revenue of ER4 for the last quarter is 271.00 M CHF, and it's 16.37% higher compared to the previous quarter. The net income of Q1 24 is 8.12 M CHF.